CRISPR and More Delicious
Article
CRISPR and More Delicious
Posted on
CRISPR-Cas9 Bioremediation
Article
CRISPR-Cas9 Bioremediation
Posted on
Unlocking the power of Prokaryotes
Article
Unlocking the power of Prokaryotes
Posted on
Opening Pandoras Box:
Article
Opening Pandoras Box:
Posted on
Three Blind Mice
Article
Three Blind Mice
Posted on
A Letter from the CEO
  ERS Genomics stands as the global leader in CRISPR/Cas9 licensing, uniquely positioned at the intersection of ...
Prime Editing
CRISPR/Cas9 Prime Editing is a novel gene editing technique that utilizes a modified Cas9 protein to introduce ...
CRISPR and More Delicious
  The United Nations predicts that there will be an additional 2.2 billion people on the planet ...
CRISPR-Cas9 Bioremediation
A new era for environmental recovery Population growth and industrialisation has led to harmful pollution of our air, ...
Unlocking the power of Prokaryotes
CRISPR/Cas9 technology has emerged as a revolutionary tool in the field of genetics and biotechnology, allowing for ...
Opening Pandoras Box:
Melting icecaps, ancient viruses and the evolution of giant Pandoravirus revealed by CRISPR/Cas9.   The Arctic region is ...
Three Blind Mice
How CRISPR/Cas9 treating visual impairment in animals is ushering in a new era of gene therapy.   Or ...
CRISPR on your wrist.
Wearable CRISPR Microneedle Patch for Extraction and Real-Time Monitoring of Cell-Free DNA. The field of wearable technology ...
Feathered Pharmaceuticals
COULD CHICKENS BE THE FUTURE OF BIOTECHNOLOGY? Part I: Revolutionary Transgenesis Approach In the ever-evolving landscape of ...
Latest Press Releases
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
Posted on
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Posted on
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
Posted on

About ERS

ERS was founded in 2014.

No, ERS is privately owned.

Although our team has significant expertise in genome editing, ERS is focused on licensing of the patents to enable others to use the technology and so we do not offer ancillary services.

Yes, that can be found here.